📰 Abt News
Page 187 - Abt News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Abt. Real-time updates on events, politics, business and more.
April 2, 2023
Mascoma Wealth Management LLC decreased its holdings in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 31.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,162 shares of the healthcare product maker’s stock after selling 522 shares during […]
April 2, 2023
Abbott Laboratories (NYSE:ABT – Get Rating) had its target price decreased by Bank of America from $125.00 to $115.00 in a research report report published on Thursday morning, The Fly reports. A number of other research firms also recently issued reports on ABT. Mizuho lifted their price objective on shares of Abbott Laboratories from $105.00 […]
April 2, 2023
Oak Ridge Investments LLC trimmed its stake in Abbott Laboratories (NYSE:ABT – Get Rating) by 1.5% during the fourth quarter, HoldingsChannel.com reports. The fund owned 37,339 shares of the healthcare product maker’s stock after selling 576 shares during the period. Oak Ridge Investments LLC’s holdings in Abbott Laboratories were worth $4,099,000 at the end of […]
April 2, 2023
Schear Investment Advisers LLC purchased a new stake in shares of Abbott Laboratories (NYSE:ABT – Get Rating) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 3,933 shares of the healthcare product maker’s stock, valued at approximately $432,000. Other large investors have also made […]
April 2, 2023
Koshinski Asset Management Inc. bought a new position in Abbott Laboratories (NYSE:ABT – Get Rating) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 35,816 shares of the healthcare product maker’s stock, valued at approximately $3,932,000. Other hedge funds also recently made changes to […]
April 2, 2023
Fulcrum Capital LLC grew its position in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 8.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 53,685 shares of the healthcare product maker’s stock after acquiring an additional 4,236 shares […]
April 1, 2023
Abbott Laboratories (NYSE:ABT – Get Rating) had its target price increased by SVB Leerink from $90.00 to $102.00 in a report published on Friday morning, Stock Target Advisor reports. SVB Leerink currently has a market perform rating on the healthcare product maker’s stock. A number of other research firms have also commented on ABT. Bank […]
April 1, 2023
Harbor Investment Advisory LLC grew its position in Abbott Laboratories (NYSE:ABT – Get Rating) by 2.5% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 29,109 shares of the healthcare product maker’s stock after acquiring an additional 721 shares during the period. Harbor Investment Advisory LLC’s holdings in Abbott Laboratories were worth $3,196,000 at […]
April 1, 2023
Forum Financial Management LP raised its holdings in Abbott Laboratories (NYSE:ABT – Get Rating) by 0.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 55,154 shares of the healthcare product maker’s stock after purchasing an additional 211 shares during the quarter. Forum […]
April 1, 2023
Eudaimonia Advisors LLC trimmed its stake in shares of Abbott Laboratories (NYSE:ABT – Get Rating) by 6.9% in the 4th quarter, Holdings Channel reports. The firm owned 2,157 shares of the healthcare product maker’s stock after selling 161 shares during the period. Eudaimonia Advisors LLC’s holdings in Abbott Laboratories were worth $237,000 as of its […]